Estimating the changing burden of disease attributable to high body mass index in South Africa for 2000, 2006 and 2012
DOI:
https://doi.org/10.7196/SAMJ.2022.v112i8b.16488Keywords:
High BMIAbstract
Background. A high body mass index (BMI) is associated with several cardiovascular diseases, diabetes and chronic kidney disease, cancers, and other selected health conditions.
Objectives. To quantify the deaths and disability-adjusted life years (DALYs) attributed to high BMI in persons aged ≥20 years in South Africa (SA) for 2000, 2006 and 2012.
Methods. The comparative risk assessment (CRA) methodology was followed. Meta-regressions of the BMI mean and standard deviation from nine national surveys spanning 1998 - 2017 were conducted to provide estimates by age and sex for adults aged ≥20 years. Population attributable fractions were calculated for selected health outcomes using relative risks identified by the Global Burden of Disease Study (2017), and applied to deaths and DALY estimates from the second South African National Burden of Disease Study to estimate the burden attributed to high BMI in a customised Microsoft Excel workbook. Monte Carlo simulation-modelling techniques were used for the uncertainty analysis. BMI was assumed to follow a log-normal distribution, and the theoretical minimum value of BMI below which no risk was estimated was assumed to follow a uniform distribution from 20 kg/m2 to 25 kg/m2.
Results. Between 2000 and 2012, mean BMI increased by 6% from 27.7 kg/m2 (95% confidence interval (CI) 27.6 - 27.9) to 29.4 kg/m2 (95% CI 29.3 - 29.5) for females, and by 3% from 23.9 kg/m2 (95% CI 23.7 - 24.1) to 24.6 kg/m2 (95% CI 24.5 - 24.8) for males. In 2012, high BMI caused 58 757 deaths (95% uncertainty interval (UI) 46 740 - 67 590) or 11.1% (95% UI 8.8 - 12.8) of all deaths, and 1.42 million DALYs (95% UI 1.15 - 1.61) or 6.9% (95% UI 5.6 - 7.8) of all DALYs. Over the study period, the burden in females was ~1.5 - 1.8 times higher than that in males. Type 2 diabetes mellitus became the leading cause of death attributable to high BMI in 2012 (n=12 382 deaths), followed by hypertensive heart disease (n=12 146), haemorrhagic stroke (n=9 141), ischaemic heart disease (n=7 499) and ischaemic stroke (n=4 044). The age-standardised attributable DALY rate per 100 000 population for males increased by 6.6% from 3 777 (95% UI 2 639 - 4 869) in 2000 to 4 026 (95% UI 2 831 - 5 115) in 2012, while it increased by 7.8% for females from 6 042 (95% UI 5 064 - 6 702) to 6 513 (95% UI 5 597 - 7 033).
Conclusion. Average BMI increased between 2000 and 2012 and accounted for a growing proportion of total deaths and DALYs. There is a need to develop, implement and evaluate comprehensive interventions to achieve lasting change in the determinants and impact of overweight and obesity, particularly among women.
References
Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017;390(10113):2627- 2642. https://doi.org/10.1016/S0140-6736(17)32129-3
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016;387(10026):1377-1396. https://doi.org/10.1016/s0140-6736(16)30054-x
Haslam DW, James WP. Obesity. Lancet 2005;366(9492):1197-1209. https://doi.org/10.1016/s0140- 6736(05)67483-1
O’Brien PD, Hinder LM, Callaghan BC, Feldman EL. Neurological consequences of obesity. Lancet Neurol 2017;16(6):465-477. https://doi.org/10.1016/s1474-4422(17)30084-4
Van Gaal LF, Mertens IL, de Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444(7121):875-880. https://doi.org/10.1038/nature05487
Redinger RN. The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol 2007;3(11):856-863
Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 2014;7:587-591. https://doi.org/10.2147/dmso.s67400
Fosam A, Perry RJ. Current mechanisms in obesity and tumor progression. Curr Opin Clin Nutr Metab Care 2020;23(6):395-403. https://doi.rg/10.1097/mco.0000000000000690
Kovesdy CP, Furth SL, Zoccali C. Obesity and kidney disease: Hidden consequences of the epidemic. J Nephrol 2017;30(1):1-10. https://doi.org/10.1007/s40620-017-0377-y
Di Angelantonio E, Bhupathiraju SN, Wormser D, et al.; Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 2016;388(10046):776-786. https://doi.org/10.1016/s0140-6736(16)30175-1
World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization, 2000. https://apps.who.int/iris/ handle/10665/42330 (accessed 8 November 2019).
Steinberger J, Jacobs DR, Raatz S, Moran A, Hong CP, Sinaiko AR. Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. Int J Obes (Lond) 2005;29(11):1346-1352. https://doi. org/1038/sj.ijo.0803026
Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes 1985;9(2):147-153
Aronne LJ, Segal KR. Adiposity and fat distribution outcome measures: Assessment and clinical
implications. Obes Res 2002;10(S11):14S-21S. https://doi.org/10.1038/oby.2002.184
Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr 2009;89(4):1213-1219. https://doi.org/10.3945/ajcn.2008.26698
United Nations. Transforming Our World: The 2030 Agenda for Sustainable Development. Resolution A/RES/70/1. New York: United Nations General Assembly: United Nations, 25 September 2015. https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20
Sustainable%20Development%20web.pdf (accessed 9 October 2019).
Joubert J, Norman R, Bradshaw D, et al. Estimating the burden of disease attributable to excess body
weight in South Africa in 2000. S Afr Med J 2007;97(8, Pt 2):683-690.
Pillay-van Wyk V, Msemburi W, Laubscher R, et al. Mortality trends and differentials in South Africa
from 1997 to 2012: Second National Burden of Disease Study. Lancet Glob Health 2016;4(9):e642-e653.
https://doi.org/10.1016/S2214-109X(16)30113-9
Murray CJ, Ezzati M, Lopez AD, Rodgers A, vander Hoorn S. Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr 2003;1(1):1. https://doi. org/10.1186/1478-7954-1-1
Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors. Lancet 1997;349(9063):1436-1442. https://doi.org/10.1016/S0140-6736(96)07495-8
Pillay-van Wyk V, Roomaney RA, Nglazi MD, et al. Can non-fatal burden estimates from the Global Burden of Disease study be used locally? An investigation using models of stroke and diabetes for South Africa. Glob Health Action 2021;14(1):1856471. https://doi.org/10.1080/16549716.2020.1856471
National Department of Health. South Africa Demographic and Health Survey 1998 [dataset]. 1999. https://dhsprogram.com/methodology/survey/survey-display-113.cfm (accessed 20 October 2020).
National Department of Health. South Africa Demographic and Health Survey 2003 [dataset]. 2007. https://dhsprogram.com/methodology/survey/survey-display-113.cfm (accessed 20 October 2020).
National Department of Health, Statistics South Africa, South African Medical Research Council and ICF. South Africa Demographic and Health Survey 2016 [dataset]. 2019. www.statssa.gov.za/ publications/Report%2003-00-09/Report%2003-00-092016.pdf (accessed 20 October 2020).
Southern Africa Labour and Development Research Unit. National Income Dynamics Study Wave 1, 2008 [dataset]. Version 7.0.0. 2018; https://microdata.worldbank.org/index.php/catalog/900/study- description (accessed 20 October 2020).
Southern Africa Labour and Development Research Unit. National Income Dynamics Study Wave 2, 2010 - 2011 [dataset]. Version 4.0.0. 2018. https://microdata.worldbank.org/index.php/catalog/1294/ study-description (accessed 20 October 2020).
Southern Africa Labour and Development Research Unit. National Income Dynamics Study Wave 3, 2012 [dataset]. Version 3.0.0. 2012. https://datacatalog.worldbank.org/dataset/south-africa-national- income-dynamics-study-2012 (accessed 20 October 2020).
Southern Africa Labour and Development Research Unit. National Income Dynamics Study Wave 4, 2014 - 2015 [dataset]. Version 2.0.0. 2012. https://microdata.worldbank.org/index.php/catalog/2595 (accessed 20 October 2020).
Southern Africa Labour and Development Research Unit. National Income Dynamics Study Wave 5, 2017 [dataset]. Version 1.0.0. 2012. https://www.datafirst.uct.ac.za/dataportal/index.php/catalog/712 (accessed 20 October 2020).
Shisana O, Labadarios D, Rehle T, et al. The South African National Health and Nutrition Examination Survey (SANHANES-1) [dataset]. 2014. http://datacuration.hsrc.ac.za/ (accessed 20 October 2020).
Pillay-van Wyk V, Roomaney R, Awotiwon O, et al. Burden of Disease Review Manager for Systematic Review of Observational Studies: Technical report and user guide. Cape Town: South African Medical Research Council, 2018. https://www.samrc.ac.za/sites/default/files/files/2021-12-01/BODREVMAN%20 Technical%20User%20GuideV2_0.pdf (accessed 30 March 2022).
Doi SA, Thalib L. A quality-effects model for meta-analysis. Epidemiology 2008;19(1):94-100. https://doi. org/10.1097/EDE.0b013e31815c24e7
Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. Contemp Clin Trials 2015;45(Pt A):130-138. https://doi.org/10.1016/j.cct.2015.05.009
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990 - 2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1923-1994. https://doi.org/10.1016/s0140-6736(18)32225-6
Pillay-van Wyk V, Laubscher R, Msemburi W, et al. Second South African National Burden of Disease Study: Data cleaning, validation and SA NBD List. Cape Town: South African Medical Research Council, 2014. https://www.samrc.ac.za/sites/default/files/files/2021-12-01/Mapping%20of%20cause%20lists.pdf (accessed 30 March 2022).
Barendregt JJ. EpigearXL. https://www.epigear.com/Products/EpigearXL/epigearxl.html (accessed 20 October 2021).
Dorrington RE. Alternative South African mid-year estimates, 2013. Cape Town: University of Cape Town, 2013. http://www.commerce.uct.ac.za/Research_Units/CARE/Monographs/Monographs/mono13. pdf (accessed 20 October 2020).
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardisation of rates: A new WHO standard. Geneva: World Health Organization, 2001. http://www.who.int/healthinfo/ paper31.pdf (accessed 30 March 2022).
Barendregt JJ. Ersatz version 1.35. 2017. http://www.epigear.com (accessed 30 March 2022).
Barendregt JJ. The effect size in uncertainty analysis. Value Health 2010;13(4):388-391. https://doi.
org/10.1111/j.1524-4733.2009.00686.x
Manne-Goehler J, Baisley K, Vandormael A, et al. BMI and all-cause mortality in a population-based cohort in rural South Africa. Obesity (Silver Spring) 2020;28(12):2414-2423. https://doi.org/10.1002/oby.23005 42. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury
attributable to 67 risk factors and risk factor clusters in 21 regions, 1990 - 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2224-2260. https://doi.org/10.1016/s0140- 6736(12)61766-8
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990 - 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396(10258):1223-1249. https://doi.org/10.1016/S0140-6736(20)30752-2 https://doi.org/10.1016/ S0140-6736(18)33192-1
Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 2012;10:22. https://doi.org/10.1186/1478-7954-10-22
National Department of Health, South Africa. National Strategic Plan for the Prevention and Control of Non-communicable Diseases 2013 - 17. Pretoria: NDoH, 2013. http://www.hsrc.ac.za/uploads/ pageContent/3893/NCDs%20STRAT%20PLAN%20%20CONTENT%208%20april%20proof.pdf (accessed 30 March 2022).
Swinburn B, Dietz W, Kleinert S. A Lancet Commission on obesity. Lancet 2015;386(10005):1716-1717.
https://doi.org/10.1016/S0140-6736(15)00722-9
Chopra M, Darnton-Hill I. Tobacco and obesity epidemics: Not so different after all? BMJ 2004;328(7455):1558-1560. https://doi.org/10.1136/bmj.328.7455.1558
Kleinert S, Horton R. Obesity needs to be put into a much wider context. Lancet 2019;393(10173): 724-726. 49. Swinburn BA, Kraak VI, Allender S, et al. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report. Lancet 2019;393(10173):791-846. https://doi.org/10.1016/S0140-
(18)32822-8
National Department of Health, South Africa. Strategic Plan for the Prevention and Control of Obesity in South Africa 2015 - 2020. Pretoria: NDoH, 2015. https://health-e.org.za/wp-content/uploads/2015/12/ National-Strategy-for-prevention-and-Control-of-Obesity-4-August-latest.pdf (accessed 6 February 2021).
Pratt CA, Loria CM, Arteaga SS, et al. A systematic review of obesity disparities research. Am J Prev Med 2017;53(1):113-122. https://doi.org/10.1016/j.amepre.2017.01.041
National Treasury, South Africa. Taxation of sugar sweetened beverages: Policy paper. 8 July 2016. https:// www.gov.za/sites/default/files/gcis_document/201608/policy-paper-and-proposal-taxation-sugar- sweetened-beverages.pdf (accessed 20 October 2020).
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
